I-131-Apamistamab (Iomab-B™)
131I-Apamistamab (131I-BC8, Iomab-B™) is an anti-CD45 radioimmunotherapy for the [...]
131I-Apamistamab (131I-BC8, Iomab-B™) is an anti-CD45 radioimmunotherapy for the [...]
131I-Iopofosine (131I-CLR-131, 131I-CLR-1404, 131I-NM404) is a small molecule, an alkyl [...]
153Sm-DOTMP (153Sm-CycloSAM) is a bone pain palliation agent under [...]
177Lu-Edotreotide (177Lu--Octreotide, 177Lu-Solucin®) is a radiolabeled somatostatin analogue developed [...]
177Lu-IPN-01087 (177Lu-3BP-227) is a neurotensin antagonist peptide labeled with 177Lu [...]
177Lu-TLX250 (177Lu-Lutarex®, 177Lu-Girentuximab), a Lutetium-177-labeled monoclonal antibody is being developed [...]
188Re-P2045 (BAY86-5284, Tozaride) is a 11-amino acid proprietary somatostatin [...]
212Pb-DOTAMTATE (212Pb-AlphaMedix™) is a somatostatin analogue labeled with Lead-212 [...]
225Ac-FPI-1434 (225Ac-FPX-01) is an alpha labeled antibody under development for [...]
225Ac-Lintuzumab (225Ac-Actimab-A™, 225Ac-DOTA-huM195) is the new name of the lead [...]